TAAR1 and Sepsis: The most commonly used immunomodulatory drugs in clinical treatments are Tα1 and ustekin, and the results of one study showed that immunotherapy reduced the incidence of 28 days death in patients with severe sepsis but had no effect on the length of ICU stay, duration of mechanical ventilation, or use of vasoactive drugs and antibiotics [43].